In consequence, it is likely that the high levels of CCL20 induced by ADO through the hypotaurine/NF-κB signaling axis in glioma may also function with NF-κB in a positive feedforward loop to promote cancer stemness and drive tumor progression. The gene discussed is NFKB1; the disease is central nervous system cancer.